Privia Health Reports Strong Q1 Operational Growth, Doubles Revolving Credit Facility to $250M
PRVA sits 32% above its 52-week low of $18.77.
Summary
Privia Health Group announced strong Q1 2026 financial results, including significant revenue and Adjusted EBITDA growth, alongside a substantial increase and extension of its revolving credit facility to $250 million.
Key Events · Earnings and Guidance · PRVA
-
Strong Q1 2026 Financial Performance
Revenue increased by 25.8% to $603.8 million, operating income grew by 42.2% to $7.4 million, and Adjusted EBITDA rose by 36.3% to $36.7 million compared to Q1 2025.
-
Key Operational Metrics Show Growth
Implemented Providers increased by 13.6% to 5,535, and Attributed Lives grew by 26.5% to 1.6 million as of March 31, 2026, demonstrating continued expansion.
-
Revolving Credit Facility Doubled and Extended
The company amended its Revolving Credit Agreement on May 6, 2026, increasing the facility from $125 million to $250 million and extending the maturity date to 2031. No amounts were outstanding as of March 31, 2026.
-
GAAP Net Income Decrease Attributed to Tax Impacts
Net income attributable to Privia Health Group, Inc. decreased by 27.4% to $3.1 million, primarily due to higher provision for income taxes stemming from share-based compensation related to equity award vesting and exercises.
Analysis · PRVA · Industrial Applications And Services
Privia Health Group reported robust operational and revenue growth for Q1 2026, with significant increases in revenue, operating income, and Adjusted EBITDA. The company also expanded its provider network and attributed lives, indicating continued strategic execution. Concurrently, the company proactively strengthened its financial flexibility by doubling its revolving credit facility to $250 million and extending its maturity to 2031, providing substantial liquidity and runway. While GAAP net income decreased, this was primarily due to non-operational tax impacts related to equity awards, rather than core business performance. This filing signals strong underlying business momentum and enhanced financial stability.
At the time of this filing, PRVA was trading at $24.71 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3B. The 52-week trading range was $18.77 to $26.51. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.